CASP3 and neoplasm: The one exception occurred in a tumor with only mild-to-moderate (1-2+) T-cell lymphocytic infiltration despite two imidazoquinoline treatments; notably, this one tumor was of large size and had minimal (<5% of tumor) apoptosis by cleaved caspase-3 staining, suggesting resistance to imidazoquinoline.